HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

RNA adenosine deaminase (ADAR1) alleviates high-fat diet-induced nonalcoholic fatty liver disease by inhibiting NLRP3 inflammasome.

Abstract
Nonalcoholic fatty liver disease (NAFLD) is a chronic inflammatory disease in which nucleotide-binding domain of leucine-rich repeat protein 3 (NLRP3) inflammasome plays an important role. The present research was aimed to explore the protective function of ADAR1, an RNA editing enzyme, against inflammatory damages in high-fat diet (HFD)-induced NAFLD through inhibiting NLRP3 inflammasome and subsequent inflammation. A total of 30 patients with NAFLD were investigated, and ADAR1 mRNA expression in peripheral blood monocytes surveyed. The in vivo study used lentivirus to explore the function of ADAR1 overexpression in the HFD-induced mouse model of NAFLD. The in vitro study used lentivirus and siRNA to explore the function of ADAR1 on the NLRP3 inflammasome activation in THP-1 cells. Results shown that the ADAR1 expression was upregulated in NAFLD patients in comparison to healthy controls. In vivo, the upregulation of ADAR1 impaired NLRP3 inflammasome activation and alleviated liver disease in HFD mice in comparison to the control group. Moreover, ADAR1 overexpression attenuated NLRP3 inflammasome in lipopolysaccharide (LPS)+ palmitic acid (PA)-induced THP-1 cells, while ADAR1 knockdown increased the NLRP3 inflammasome activation. Furthermore, we speculated that c-Jun may participate in ADAR1's inhibition of NLRP3 inflammasome. Our results suggested that ADAR1 is a potential treatment target for NAFLD via regulating the activation of NLRP3 inflammasome.
AuthorsRong Xiang, Yuxing Liu, Liangliang Fan, Boyue Jiang, Fang Wang
JournalLaboratory investigation; a journal of technical methods and pathology (Lab Invest) Vol. 102 Issue 10 Pg. 1088-1100 (10 2022) ISSN: 1530-0307 [Electronic] United States
PMID35690649 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2022. The Author(s), under exclusive licence to United States and Canadian Academy of Pathology.
Chemical References
  • Inflammasomes
  • Lipopolysaccharides
  • NLR Family, Pyrin Domain-Containing 3 Protein
  • Nlrp3 protein, mouse
  • Nucleotides
  • RNA, Messenger
  • RNA, Small Interfering
  • Palmitic Acid
  • ADAR1 protein, mouse
  • Adenosine Deaminase
Topics
  • Adenosine Deaminase (genetics, metabolism)
  • Animals
  • Diet, High-Fat (adverse effects)
  • Inflammasomes (metabolism)
  • Lipopolysaccharides (pharmacology)
  • Liver (metabolism)
  • Mice
  • Mice, Inbred C57BL
  • NLR Family, Pyrin Domain-Containing 3 Protein (genetics, metabolism)
  • Non-alcoholic Fatty Liver Disease (metabolism)
  • Nucleotides (metabolism)
  • Palmitic Acid (metabolism, pharmacology)
  • RNA, Messenger (metabolism)
  • RNA, Small Interfering (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: